CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of the Specificity, Sensitivity, and Clinical Correlation of Cell-based Assay (CBA) and CBA-TSA (Tyramide Signal Amplification) in Detecting AQP4, MOG, and NMDAR-IgG in Central Nervous System Diseases; a National Multicenter Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05414890
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:36.923045+00:00
Published At: 2022-06-10T00:00:00+00:00
Record Updated At: 2022-06-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["NMO Spectrum Disorder", "NMDA-R Encephalitis", "Diagnostic Self Evaluation", "Immune System Diseases", "Nervous System Diseases", "Autoimmune Diseases of the Nervous System", "Autoimmune Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-06-10"
protocolSection.identificationModule.nctId: "NCT05414890"
protocolSection.identificationModule.officialTitle: "Comparison of the Specificity, Sensitivity, and Clinical Correlation of Cell-based Assay (CBA) and CBA-TSA (Tyramide Signal Amplification) in Detecting AQP4, MOG, and NMDAR-IgG in Central Nervous System Diseases; a National Multicenter Study"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.